Search Results 51-60 of 12518 for edward loftus

  1. A Study To Evaluate The Effectiveness And Safety Of MEDI2070 In Subjects With Active Moderate To Severe Crohn's Disease - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus JR, M.D.. Closed for enrollment ...

  2. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  3. Study Of GS-1427 In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  5. A Study Of Icotrokinra In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus JR, M.D.. Contact information: Troy Ofstie. 5072664728. Contact UsIBDRESEARCH@mayo.edu. Open for enrollment. More information. Publications.

  6. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  7. Efficacy And Safety Of Vedolizumab Subcutaneous (SC) As Maintenance Therapy In Crohn's Disease - Mayo Clinic

    Edward Loftus JR, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non ...

  8. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Combining talimogene laherparepvec with immunotherapies in melanoma and other solid ...

  9. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Assess the Effectiveness and Safety of Risankizumab in Subjects with Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...